Market capitalization | $23.87m |
Enterprise Value | $76.86m |
P/E (TTM) P/E ratio | negative |
EV/Sales (TTM) EV/Sales | 0.31 |
P/S ratio (TTM) P/S ratio | 0.10 |
P/B ratio (TTM) P/B ratio | 0.14 |
Revenue growth (TTM) Revenue growth | -51.94% |
Revenue (TTM) Revenue | $246.65m |
EBIT (operating result TTM) EBIT | $-23.45m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
1 Analyst has issued a forecast Zepp Health ADR A ADR:
1 Analyst has issued a forecast Zepp Health ADR A ADR:
Jun '24 |
+/-
%
|
||
Revenue | 247 247 |
52%
52%
|
|
Gross Profit | 88 88 |
12%
12%
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -23 -23 |
56%
56%
|
Net Profit | -26 -26 |
39%
39%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Zepp Health Corp. engages in the development, manufacture, and sale of smart wearable technology devices. It operates through Xiaomi Wearable Products, and Self-branded Products and Others segments. The Xiaomi Wearable Products segment comprises of sales of Xiaomi-branded products. The Self-branded Products and Others segment includes self-branded products. The company was founded by Huang Wang in December 2014 and is headquartered in Hefei, China.
Head office | Cayman Islands |
CEO | Wang Huang |
Employees | 839 |
Founded | 2013 |
Website | www.zepp.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.